United States Coronary Artery Disease Market & Competitive Landscape 2014-2019 & 2024

Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "US Coronary Artery Disease Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Coronary Artery Disease pipeline products, Coronary Artery Disease epidemiology, Coronary Artery Disease market valuations and forecast, Coronary Artery Disease drugs sales and competitive landscape in the US.

The research is classified into seven sections - Coronary Artery Disease treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

• Coronary Artery Disease pipeline: Find out the products in clinical trials for the treatment of Coronary Artery Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
• Coronary Artery Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Coronary Artery Disease in the US
• Coronary Artery Disease drugs: Identify key products marketed and prescribed for Coronary Artery Disease in the US, including trade name, molecule name, and company
• Coronary Artery Disease drugs sales: Find out the sales revenues of Coronary Artery Disease drugs in the US
• Coronary Artery Disease market valuations: Find out the market size for Coronary Artery Disease drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
• Coronary Artery Disease drugs market share: Find out the market shares for key Coronary Artery Disease drugs in the US

Benefits of this Research

• Support monitoring and reporting national Coronary Artery Disease market analysis and sales trends
• Track competitor drugs sales and market share in the US Coronary Artery Disease market
• Track competitive developments in Coronary Artery Disease market and present key issues and learnings
• Synthesize insights for Coronary Artery Disease market and products to drive business performance
• Answer key business questions about the Coronary Artery Disease market
• Evaluate commercial market opportunity assessment, positioning, and segmentation for Coronary Artery Disease products
• Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Coronary Artery Disease Treatments
2) Coronary Artery Disease Pipeline
3) US Coronary Artery Disease Epidemiology
4) Marketed Drugs for Coronary Artery Disease in US
5) US Coronary Artery Disease Market Size and Forecast
6) US Coronary Artery Disease Products Sales and Forecast
7) US Coronary Artery Disease Market Competitive Landscape
8) Methodology

List of Tables
1. Coronary Artery Disease Phase 3 Clinical Trials, 2019
2. Coronary Artery Disease Phase 2 Clinical Trials, 2019
3. Coronary Artery Disease Phase 1 Clinical Trials, 2019
4. Coronary Artery Disease Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Coronary Artery Disease, US, 2018
6. Coronary Artery Disease Market Size and Forecast ($), US, 2014 - 2024
7. Coronary Artery Disease Product Sales ($), US, 2014 - 2024

List of Figures
1. Coronary Artery Disease Epidemiology, US, 2014 - 2024
2. Coronary Artery Disease Market Size and Forecast ($), US, 2014 - 2024
3. Coronary Artery Disease Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/sjy1ac

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs